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Objectives: This study aimed to determine the association of rs2430561 and rs4073 polymorphisms in the
Interferon gamma (IFN-ɤ) and Interleukin 8 (IL-8) genes, respectively, with hepatitis C virus-related oral lichen
planus and disease severity.
Design: This is a case-control study. 60 subjects were equally divided into patients with and without oral lichen
planus. They were further subdivided into hepatitis C virus seropositive and seronegative patients. All patients
were genotyped for IFN-γ rs2430561 thymine to adenine (T > A) and IL-8 rs4073 adenine to thymine (A > T)
polymorphisms. All patients with oral lichen planus had their lesions measured and documented using the
Escudier scoring system.
Results: Disease activity was signiﬁcantly higher in the "oral lichen planus/hepatitis C virus-positive" patients
than in the "oral lichen planus/hepatitis C virus-negative" patients (P = 0.003). IFN-γ rs2430561 T > A and IL-8
rs4073 A > T genotypes and allele frequencies were not associated with the oral lichen planus group or the
normal group. Stratiﬁcation of the two groups into HCV and non-HCV-infected patients or into erosive and nonerosive types revealed no signiﬁcant associations. The “A-allele-containing" genotypes of IL-8 rs4073 A > T
were signiﬁcantly more prevalent in the patients with oral lichen planus than in those without.
Conclusion: Hepatitis C virus infection is associated with the development of erosive oral lichen planus. The Aallele of IL-8 rs4073 A > T may have a role in the development and progression of oral lichen planus.

1. Introduction
Oral lichen planus (OLP) is part of a mucocutaneous disorder that
usually aﬀects mucosal surfaces, skin, nails and the scalp (Al-Hashimi
et al., 2007). The reported prevalence of oral lichen planus ranges from
0.1% to 4% (Garcia-Garcia et al., 2013).
One of the most widely proposed oral lichen planus etiologies is
hepatitis C virus (HCV) infection (Carrozzo et al., 2007). hepatitis C
virus leads to an increase in T helper 1 cytokine production in the already dysregulated oral lichen planus environment, resulting in inﬂammation and the various clinical manifestations characteristic of lichen planus (Lu, Zhang, Sun, Du, & Zhou, 2015).
Interferon Gamma (IFN-γ) is involved in the pathogenesis of both

oral lichen planus and hepatitis C virus infection. In oral lichen planus,
it acts as a constant "on" switch for major histocompatibility complex
classes I and II, facilitating the initiation and maintenance of oral lichen
planus activity (Carrozzo, 2014). In hepatitis C virus infection, Interferon Gamma shows a dichotomous role by contributing to the selfinﬂicted inﬂammatory process while also protecting against further
spread of viral infection (Carrozzo & Pellicano, 2008).
Another factor involved in the pathogenesis of oral lichen planus
and hepatitis C virus infection is Interleukin 8 (IL-8), which recruits
inﬂammatory cells and thereby adds to the high oxidative stress in oral
lichen planus (Eslami et al., 2015). Interleukin 8 impairs keratinocyte
repair, thus contributing to the basement membrane disruption observed in oral lichen planus and causing erosive transformation of

Abbreviations: A, adenine; CI, conﬁdence interval; HCV, hepatitis C virus; IFN- ɤ, interferon gamma; IL-8, interleukin 8; OLP, oral lichen planus; OR, odds ratio;
PCR, polymerase chain reaction; SNP, single nucleotide polymorphism; T, thymine
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papular type oral lichen planus (Femiano & Scully, 2005).
Interleukin 8 is also presumed to have a role in the dysplastic
changes in oral lichen planus (Mittal, Shankari, & Palaskar, 2012). Interleukin 8 up-regulates vascular endothelial growth factor expression,
which increases angiogenesis, thus facilitating lymphocytic inﬁltration
and long-term lymphocyte accumulation, leading to dysplastic changes
in oral lichen planus (Mittal et al., 2012).
Gene polymorphism detection is a method of thoroughly investigating the pathogenesis of diseases. Polymorphisms within regulatory sequences or introns may have a signiﬁcant eﬀect on transcription, as they usually result in an altered promoter region,
subsequently changing the structure of the transcription binding site or
the structure of enhancers and silencers within introns (Colobran, PujolBorrell, Armengol, & Juan, 2007).
Both the Interferon Gamma and Interleukin 8 genes have noncoding single nucleotide polymorphisms that may increase the risk of
greater disease severity in one of their forms. The single nucleotide
polymorphisms rs2430561 is within the ﬁrst intron of Interferon
Gamma, where the transversion of thymine (T) to adenine (A) causes
the preferential binding of nuclear transcription factor nuclear factor
kappa beta (Kimkong, Nakkuntod, Sodsai, Hirankarn, & Kitkumthorn,
2012; Smith & Denning, 2014), leading to upregulated IFN-γ production and potentially contributing to oral lichen planus chronicity.
For Interleukin 8, the single nucleotide polymorphisms of interest,
rs4073, otherwise known as −251 A/T, is located in the promoter region of the gene at its transcription site (Hildebrand et al., 2007) and is
known to exert a strong inﬂuence on protein synthesis. Additionally,
this polymorphism was previously associated with oral lichen planus
severity (Lu et al., 2015). Despite its implication in the poor outcome of
many diseases (Hull, Thomson, & Kwiatkowski, 2000), this single nucleotide polymorphism has rarely been studied in oral lichen planus.
Therefore, this study aimed to determine the associations of the
rs2430561 and rs4073 polymorphisms in the Interferon Gamma and
Interleukin 8 genes, respectively, with hepatitis C virus -related oral
lichen planus and disease severity.

Oral lichen planus patients were diagnosed according to the modiﬁed World Health Organization’s diagnostic criteria for oral lichen
planus (van der Meij & van der Waal, 2003). Patients with suspected
oral lichenoid reaction or histological signs of dysplasia were excluded
from the study.
Oral lichen planus patients underwent clinical scoring according to
the scoring system developed by the Oral Medicine Unit in King's
College by Escudier et al. (2007) (Escudier et al., 2007). This score
considers lesion extent, oral lichen planus severity and pain on a scale
of 0–10, and the total Escudier score is determined as the sum of these
individual parameter scores (Escudier et al., 2007).
For genotyping, 2 mm of tissue was shaved oﬀ the acquired diagnostic biopsies from the oral lichen planus patients, while tissue samples from the control subjects with no hepatitis C virus infection were
obtained from excess tissue from periodontal surgeries, mainly crown
lengthening surgeries and implant placement surgeries (avoiding any
periodontally aﬀected teeth). The samples were stored in a sterile vacutioner® and kept frozen at −80 °C until DNA extraction.
Blood samples were collected from the control subjects with hepatitis C virus infection attending the hepatology clinic for follow-up as it
was unethical to obtain a tissue sample from them. A total of 3 ml of
blood was drawn from each patient by venous puncture and collected in
Ethylene diamine tetracidic acid vacutainer tubes. Whole blood was
kept at −20 °C until DNA extraction.
Because this is a case-control study, selection bias is an inherent
problem in the study design. However, there was no recall bias because
genetic investigations are not dependent on a patient’s reported history.
We attempted to reduce observer bias by using a systematic scoring
system.

2. Materials and methods

2.4. Genotyping by real time Polymerase Chain Reaction (PCR)

2.1. Recruited subjects

Real-time polymerase chain reaction was performed by the
Lightcycler 2.0 (Roche Applied Science) with the FastStart DNA
Hybprobe Mastermix Kit (Roche Diagnostics GmbH, 68298 Mannheim,
Germany) and the LightSNiPs detection mix for IFN-γ rs2430561 and IL8 rs4073 (TIB Molbiol GmbH - Eresburgstrasse 22–23, D-12103 Berlin,
Germany) containing the primers and hybridization probes required for
the reaction.
The Light Cycler HybProbe is ﬂuorescence resonance energy
transfer-based, and speciﬁc oligonucleotide probes for two sequences,
labeled with diﬀerent dyes (donor and recipient), are added to the reaction mixture in addition to the polymerase chain reaction primers.
The amount of ﬂuorescence produced by the labeled probe is directly
proportional to the amount of target DNA produced during the polymerase chain reaction process. The polymerase chain reaction was
followed by melting curve analysis.
Diﬀerentiation between the various alleles present in each sample
was based on diﬀerent dyes and melting temperatures. Each allele had a
distinctive melting peak in the melting/dissociation curve proﬁle,
which allowed clear determination of the genotype.

2.3. DNA extraction and genotyping study
The GeneJETTM Genomic DNA Puriﬁcation Kit (#K0721,
Fermentas* Life Sciences, *Fermentas UAB, V.Graiciuno 8, LT-02241
Vilnius, Lithuania) was used for DNA extraction.

This study was approved by the Research Ethics Committee of the
Faculty of Dentistry, Cairo University (approved on 10/12/2013), and
was performed in accordance with the Declaration of Helsinki. All
participants in the study provided informed consent.
A total of 60 subjects were recruited from the out-patient clinic at
the Faculty of Oral and Dental Medicine and the Hepatology Clinic,
Faculty of Medicine, Cairo University, from February 2014 to February
2016.
2.2. Study groups

• 30 oral lichen planus patients: 15 hepatitis C virus seropositive and
15 hepatitis C virus seronegative
• 30 patients with no oral lesions: 15 hepatitis C virus seropositive and
15 healthy subjects.

Patients on corticosteroids or other immunosuppressive drugs, those
with current or previous malignancy, and pregnant or breastfeeding
mothers were excluded from the study.
All 60 patients were subjected to a thorough interview regarding
their medical histories and were tested for hepatitis C virus. Testing was
done using anti−HCV antibody assay via a third-generation enzymelinked immunosorbent assay where seropositivity is detected using a
microwell reader to detect the concentration of human IgG that has
conjugated with recombinant hepatitis C virus antigen (Ortho Clinical
Diagnostics, 2009).

2.5. Statistical analysis
The results were analyzed using the IBM® SPSS® version 20 computer software package for Windows. Allele frequencies were calculated
from the observed numbers of genotypes. Genotypes and allele frequencies of IFN-γ rs2430561 T > A and IL-8 rs4073 A > T were
analyzed by the chi-square (χ2) test. Odds ratios (ORs) and 95% conﬁdence intervals (CIs) were also assessed. Correlations between clinical
190
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characteristics and the single nucleotide polymorphisms investigated
were assessed using Spearman's rank correlation coeﬃcient.

Table 1
Clinical characteristics of the recruited OLP subjects.
OLP patients (n = 30)

Erosive OLP
Cutaneous Lesion
Buccal Mucosa
Labial Mucosa
Tongue
Palate
Lip

HCV seropositive
(n = 15) (%)

HCV seronegative (n = 15) (%)

12 (80%)
5 (33.3%)
14 (93.3%)
7 (46.6%)
7 (46.6%)
5 (33.3%)
4 (26.6%)

4 (26.6%)
1 (6.6%)
14 (93.3%)
5 (33.3%)
8 (53.3%)
4 (26.6%)
0 (0%)

Clinical Score (Escudier Score) (Mean ± SD)
Site Score
8.67 ± 3.35
Activity Score
16.4 ± 7.8
Pain Score
6.8 ± 1.90
Total Escudier Score
31.87 ± 10.71

3. Results
The oral lichen planus patients and the control groups were age and
sex matched with the mean age of 55.1 ± 8.3 and 45 ± 6.7 respectively. The oral Lichen planus group was made up of 21 females and 9
males, while the controls had 17 females and 9 males (Table 1).
As the main clinical indicator, the Escudier score was compared
between OLP/ HCV seropositive and OLP/ HCV seronegative patients.
Signiﬁcantly higher activity and total Escudier scores were observed in
the OLP/ HCV patients, with p values of 0.003 and 0.008, respectively.
OLP/ HCV seropositive patients were 11 times more likely to develop
erosive OLP than OLP/ HCV seronegative patients (OR = 11,
CI = 2.0–60.5, p = 0.002). Figs. 1 and 2 show an example from the
OLP/ hepatitis C virus seropositive and OLP/ HCV seronegative groups
respectively.

7 ± 3.317
8.73 ± 4.62
6 ± 2.23
21.73 ± 8.6

Fig. 1. Showing a 61 year old male patent with HCV related OLP. His total Escudier score was 42, and he was heterozygous for both IFN-γ rs2430561 and IL-8 rs4073.
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Fig. 2. Showing a 50-year-old female medically free patient with OLP. Her Escudier score was 37, and she was heterozygous for both IFN-γ rs2430561 and IL-8
rs4073.

(r = 0.001, p = 0.9; r = 0.11, p = 0.55, respectively).

Regarding the IFN-γ rs2430561 T > A and IL-8 rs4073 A > T
genotypes and allele frequencies (Table 2), no statistically signiﬁcant
association was detected between the oral lichen planus and control
groups. Stratifying the two groups into hepatitis C virus infected and
non- infected patients or stratifying the oral lichen planus group into
erosive and non-erosive types yielded no signiﬁcant associations.
IL-8 rs4073 “A-allele-containing" genotypes (AT + AA) were signiﬁcantly more prevalent than the TT genotype in patients with oral
lichen planus than in those without (p = 0.039).
To determine whether a certain genotype causes a more severe
presentation than another, the genotype frequencies of all oral lichen
planus patients were compared against the total Escudier score. This
comparison showed no signiﬁcant diﬀerence between the IFN-γ
rs2430561 T > A and IL-8 rs4073 A > T genotypes and total Escudier
score (p = 0.4 and 0.2, respectively).
Spearman correlation was used to identify relationships between
IFN-γ rs2430561 T > A and IL-8 rs4073 A > T single nucleotide
polymorphisms, hepatitis C virus infection and clinical presentation in
oral lichen planus patients. A signiﬁcant relationship was found between hepatitis C virus infection and oral lichen planus presentation
(r = 0.47 and p = 0.009). However, no evidence of a signiﬁcant relationship was found between IFN-γ rs2430561 T > A and IL-8 rs4073
A > T single nucleotide polymorphisms and clinical outcome

4. Discussion
Egypt has the highest prevalence of hepatitis C virus infection in the
world at 14.7% (Mohamoud, Mumtaz, Riome, Miller, & Abu-Raddad,
2013), thus warranting the investigation of extra-hepatic manifestations of hepatitis C virus infection, such as oral lichen planus
(Baccaglini, Thongprasom, Carrozzo, & Bigby, 2013).
In this study, the Escudier score revealed signiﬁcantly higher oral
lichen planus activity in the hepatitis C virus seropositive patients (80%
erosive oral lichen planus) than in the hepatitis C virus seronegative
patients, conﬁrming that hepatitis C virus infection exacerbates oral
lichen planus.
This is the ﬁrst Egyptian study to explore the relationship between
single nucleotide polymorphisms and oral lichen planus severity with
respect to hepatitis C virus infection. This study also has the advantage
of extracting DNA from fresh tissue samples obtained from oral lichen
planus patients and the normal control group, while in the case of the
control group with hepatitis C virus, blood samples were obtained due
to ethical reasons.
Although the T-allele of the Interferon Gamma T/A single nucleotide polymorphism (rs2430561) was noted to be the predominant
192
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Table 2
Genotypes and allele frequencies of the studied groups.
Genotype/
Allele

OLP

Controls

Clinical Presentation

Serology

INF-γ
rs2430561

Erosive
(n = 16)

Non- Erosive
(n = 14)

HCVa
(n = 15)

Non-HCV
(n = 15)

TT

4
(25%)
10
(62.5%)
2
(12.5%)
14
(43.8%)
18
(56.3%)

6
(42.9%)
8
(57.14%)
0
(0.0%)
8
(28.6%)
20
(71.4%)

5
(33.3%)
9
(60%)
1
(6.7%)
11
(36.7%)
19
(63.3%)

3
(18.8%)
12
(75.0%)
1
(6.3%)
18
(56.3%)
14
(43.8%)

4
(28.6%)
9
(64.3%)
1
(6.3%)
17
(60.7%)
11
(39.3%)

5
(33.3%)
10
(66.7%)
0
(0.0%)
20
(66.7%)
10
(33.3%)

AT
AA
A
T
IL-8 rs4073
AA
AT
TT
A
T

a
b

a

HCV b
(n = 15)

Non- HCV
(n = 15)

5
(33.3%)
9
(60%)
1
(6.7%)
11
(36.7%)
19
(63.3%)

5
(33.3%)
9
(60%)
1
(6.7%)
11
(36.7%)
19
(63.3%)

5
(33.3%)
9
(60%)
1
(6.7%)
11
(36.7%)
19
(63.3%)

2
(13.3%)
11
(73.3%)
2
(13.3%)
15
(50%)
15
(50%)

4
(26.7%)
7
(46.7%)
4
(26.7%)
15
(50%)
15
(50%)

3
(20%)
8
(53.3%)
4
(26.7%)
14
(46.7%)
16
(53.3%)

a

Tissue Source.
Blood Source.

prognosis (Hildebrand et al., 2007). In contrast, Dan et al. (2010) found
a signiﬁcant decrease in the frequency of the A-allele in erosive oral
lichen planus patients compared with that in healthy patients and
proposed that the A-allele may have a protective eﬀect against oral lichen planus (Dan et al., 2010). These conﬂicting results could be due to
either the small sample size of this study, the sample type or the different ethnicity of the subjects. For example, according to the National
Center for Biotechnology Information dbSNP database, the A-allele was
predominant in a sample of Sub-Saharan Africans (82.49%), but it was
reported to be the minor allele in an Asian cohort (27.14%) (NCBI,
2017).
Our collective results, together with the available literature, can be
used to propose the following theory: the hepatitis C virus evades host
immunity by suppressing interferon genes and activating antagonizing
genes, such as Interleukin 8 (Gale & Foy, 2005; Mahmood et al., 2002).
Consequently, the increased production of Interleukin 8 mediated by
the presence of the A-allele (rs4073) will contribute to the suppression
of the Interferon protective eﬀect, leading to aggravation of the disease
in the form of erosive oral lichen planus, as observed in the oral lichen
planus hepatitis C virus seropositive patients.
In conclusion, this study's ﬁndings suggest that hepatitis C virus
infection can increase the severity of oral lichen planus presentation.
Furthermore, we suggest an association between the A-allele of
Interleukin 8 rs4073 and oral lichen planus pathogenesis, but little
association was found between Interferon Gamma rs2430561 and oral
lichen planus severity. However, the clinical impact of such data remains to be elucidated. We believe that this is the ﬁrst study to examine
the association between gene polymorphisms and oral lichen planus
severity in Egypt using fresh frozen tissues. This study represents a ﬁrst
step in examining oral lichen planus in this population. Further studies
with larger sample sizes and examination of the functional eﬀects of
these polymorphisms are required to better understand their role in oral
lichen planus pathophysiology.

allele, the statistical analysis showed no statistically signiﬁcant diﬀerence between the patients with oral lichen planus and those without
oral lichen planus. In partial agreement with this study, Bai et al.
(2008) and Kimkong et al. (2012) found the T-allele to be predominant,
and it was signiﬁcantly higher in oral lichen planus patients than in
controls (Kimkong et al., 2012),(Bai et al., 2008). These investigators
reported that the TT genotype of IFN-γ rs2430561 presented a two-fold
increased risk of developing oral lichen planus compared with the other
2 genotypes (AT, AA) (Kimkong et al., 2012). This discrepancy in results relative to those of Kimkong et al. (2012) may be a result of their
use oﬀormalin-ﬁxed paraﬃn-embedded tissues, which yields far lower
quality DNA than fresh frozen tissue (Bartlett & Stirling, 2003). Additionally, formalin-ﬁxed tissues have a high frequency of non-reproducible sequence alterations (Kimkong et al., 2012). Up to 1 mutation artifact per 500 bases has been recorded (Srinivasan, Sedmak, &
Jewell, 2002). Transitional C:G > T:A variants are the most frequently
detected variants (Do & Dobrovic, 2015).
Bai et al. (2008) used peripheral blood (Bai et al., 2008), while the
current study used lesional tissue. It has been reported that polymorphisms with clear eﬀects on both overall expression and splicing are
often tissue-speciﬁc (Heinzen et al., 2008). Of course, ethnic diversity
should not be overlooked, as allele frequencies can be extremely incongruent among diﬀerent ancestries and can lead to false associations
between a phenotype and an allele (Baumgartel et al., 2011).
We found that the "A-allele-containing” genotypes of Interleukin 8
rs4073 (AA + AT) were signiﬁcantly more prevalent in the oral lichen
planus patients than in those without oral lichen planus, supporting the
preferential binding of the A-allele to the transcription factor nuclear
transcription factor nuclear factor kappa beta, thus contributing to oral
lichen planus pathogenesis (Hildebrand et al., 2007). However, no
signiﬁcant diﬀerence was detected in genotype or allele frequency between the oral lichen planus and oral lichen planus -free groups. Additionally, no signiﬁcant diﬀerence was found after sub-dividing the 30
oral lichen planus patients into erosive and non-erosive types.
These results are consistent with previous reports that found the Aallele to be associated with disease progression and overall poor
193
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